AXC-715 hydrochloride
Modify Date: 2025-08-27 11:54:42
AXC-715 hydrochloride structure
|
Common Name | AXC-715 hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 2490497-93-1 | Molecular Weight | 347.89 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H26ClN5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AXC-715 hydrochlorideAXC-715 hydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1[1]. AXC-715, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants[2]. |
| Name | AXC-715 hydrochloride |
|---|
| Description | AXC-715 hydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1[1]. AXC-715, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants[2]. |
|---|---|
| Related Catalog | |
| Target |
TLR8 TLR7 |
| References |
[2]. Shelley Erin ACKERMAN, et al. Immunoconjugates targeting pd-l1. Patent WO2020190734A1. |
| Molecular Formula | C18H26ClN5 |
|---|---|
| Molecular Weight | 347.89 |